Tecan’s MCA 384 adapter plate concept provides ultimate flexibility
Publication date: 16 August 2011
Author: kdm communications
Tagged with: Tecan, Thomas U Mayer, University of Konstanz
The flexibility offered by Tecan’s MultiChannel Arm™ (MCA) 384 and Freedom EVO® liquid handling platform is vital to researchers in the Biology Department at the University of Konstanz, Germany, helping them to develop novel molecular tools for the investigation of cellular processes.
Stefanie Selent, technical assistant in the screening unit, with the Freedom EVO
Professor Thomas U Mayer explained: “We are investigating how small molecules affect protein activity, and how they may be used to activate or deactivate this activity during mitosis in living cells. We perform a variety of protein- and cell-based assays, using fluorescence-based techniques to follow the process of interest, and depend on a Freedom EVO platform equipped with the versatile MCA 384 option to reproducibly perform these screens.”
“We mainly work in 384-well format, but we also use 96-well plates for RNAi¬based screens, and so wanted a highly flexible system which could perform various assays as required. The MCA 384’s adapter plate concept allows us to automatically switch between 384- and 96-well pipetting, as well as use our existing 384-well pin tool for very low volume liquid transfers. This enables us to use a single workstation to perform a wide range of tasks, which is very important in academia, and we have been very happy with the system’s performance.”
To find out more about Tecan’s MCA 384 option, visit www.tecan.com/mca384
Advertisement:
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- Fast plasma sample cleanup with new Phree Phospholipid Removal Plates (21 May 2012)
- Two overall winners announced at prestigious national award ceremony in London’s Science Museum (18 May 2012)
- New analysis of risk stratification for TYSABRI® published in New England Journal of Medicine (18 May 2012)
- NUCYNTA® ER (tapentadol) tablets provide pain management for patients with Diabetic Peripheral Neuropathy (DPN) (18 May 2012)
- GSK statement on tender offer to acquire Human Genome Sciences (18 May 2012)
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content